Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PR.

Can't even send the message to the Market and the Targets that the stayed cases will definately continue to be pursued in District Court ?

Nothing more at all to say to the Infringers or your Shareholders ?

Perhaps the most valuable bit of information we can speculate from this pathetic and weak PR, is that PTSC is unable to participate or even threaten to prosecute any infringers until TPL's BK case sufficiently resolves itself further. It once again appears we are completely at the mercy of others for our business and investment future.

I doubt PTSC wanted to even release a PR to inform us, but rather, that they simply needed to comply with the 8K requirements of a Material Events disclosure.

Share
New Message
Please login to post a reply